How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

1,178 results for

Mycobacterium Avium Complex

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

241. Mycobacterium Kansasii (Diagnosis)

, has been reported in other countries, including Israel, Korea, [ ] Portugal, France, and Japan. Based on the analysis of identification data received by the NTM-Network European Trials Group (NET) for 20,182 patients in 30 countries across 6 continents in 2008, M kansasii was the sixth most common NTM isolated from pulmonary samples. Mycobacterium avium complex (MAC) was the most common NTM in most countries. [ ] Mortality/Morbidity The likelihood of mortality associated with M kansasii infection (...) and management of disease caused by M. avium complex, M. kansasii, and other mycobacteria. Clin Chest Med . 1989 Sep. 10(3):431-43. . Fishman JE, Schwartz DS, Sais GJ. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings. Radiology . 1997 Jul. 204(1):171-5. . O'Brien RJ. The epidemiology of nontuberculous mycobacterial disease. Clin Chest Med . 1989 Sep. 10(3):407-18. . Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis . 1992 Jul

2014 eMedicine.com

242. Mycobacterium Xenopi (Treatment)

. . Carrillo MC1, Patsios D, Wagnetz U, Jamieson F, Marras TK. Comparison of the Spectrum of Radiologic and Clinical Manifestations of Pulmonary Disease Caused by Mycobacterium avium Complex and Mycobacterium xenopi. Can Assoc Radiol J . December 2013. 47-48. . Al Jarad N, Demertzis P, Jones DJ, et al. Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. Thorax . 1996 Feb. 51(2):137-9. . American Thoracic Society (...) Mycobacterium Xenopi (Treatment) Mycobacterium Xenopi Treatment & Management: Medical Care, Surgical Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMjIzNDgwLXRyZWF0bWVudA== processing

2014 eMedicine.com

243. Mycobacterium Kansasii (Treatment)

A, Levell N, Munro C. Cutaneous Mycobacterium kansasii infection: case report and review. Clin Infect Dis . 1995 Apr. 20(4):812-7. . Davidson PT. The diagnosis and management of disease caused by M. avium complex, M. kansasii, and other mycobacteria. Clin Chest Med . 1989 Sep. 10(3):431-43. . Fishman JE, Schwartz DS, Sais GJ. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings. Radiology . 1997 Jul. 204(1):171-5. . O'Brien RJ. The epidemiology (...) Mycobacterium Kansasii (Treatment) Mycobacterium Kansasii Treatment & Management: Medical Care, Surgical Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMjIzMjMwLXRyZWF0bWVudA== processing

2014 eMedicine.com

244. Mycobacterium Xenopi (Overview)

-tuberculous mycobacteria in the sputum of HIV-infected patients: infection or colonization?. Int J STD AIDS . 2009 Mar. 20(3):193-5. . De Lorenzi D, Solano-Gallego L. Tracheal granuloma because of infection with a novel mycobacterial species in an old FIV-positive cat. J Small Anim Pract . 2009 Mar. 50(3):143-6. . Carrillo MC1, Patsios D, Wagnetz U, Jamieson F, Marras TK. Comparison of the Spectrum of Radiologic and Clinical Manifestations of Pulmonary Disease Caused by Mycobacterium avium Complex (...) al. Clinical and radiographic manifestations of uncommon pulmonary nontuberculous mycobacterial disease in AIDS patients. Chest . 1998 Jul. 114(1):138-45. . Eng RH, Forrester C, Smith SM, Sobel H. Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome. Chest . 1984 Jul. 86(1):145-7. . First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid

2014 eMedicine.com

245. Mycobacterium Kansasii (Overview)

, has been reported in other countries, including Israel, Korea, [ ] Portugal, France, and Japan. Based on the analysis of identification data received by the NTM-Network European Trials Group (NET) for 20,182 patients in 30 countries across 6 continents in 2008, M kansasii was the sixth most common NTM isolated from pulmonary samples. Mycobacterium avium complex (MAC) was the most common NTM in most countries. [ ] Mortality/Morbidity The likelihood of mortality associated with M kansasii infection (...) and management of disease caused by M. avium complex, M. kansasii, and other mycobacteria. Clin Chest Med . 1989 Sep. 10(3):431-43. . Fishman JE, Schwartz DS, Sais GJ. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings. Radiology . 1997 Jul. 204(1):171-5. . O'Brien RJ. The epidemiology of nontuberculous mycobacterial disease. Clin Chest Med . 1989 Sep. 10(3):407-18. . Wolinsky E. Mycobacterial diseases other than tuberculosis. Clin Infect Dis . 1992 Jul

2014 eMedicine.com

246. Mycobacterium Xenopi (Follow-up)

granuloma because of infection with a novel mycobacterial species in an old FIV-positive cat. J Small Anim Pract . 2009 Mar. 50(3):143-6. . Carrillo MC1, Patsios D, Wagnetz U, Jamieson F, Marras TK. Comparison of the Spectrum of Radiologic and Clinical Manifestations of Pulmonary Disease Caused by Mycobacterium avium Complex and Mycobacterium xenopi. Can Assoc Radiol J . December 2013. 47-48. . Al Jarad N, Demertzis P, Jones DJ, et al. Comparison of characteristics of patients and treatment outcome (...) SM, Sobel H. Mycobacterium xenopi infection in a patient with acquired immunodeficiency syndrome. Chest . 1984 Jul. 86(1):145-7. . First randomised trial of treatments for pulmonary disease caused by M avium intracellulare, M malmoense, and M xenopi in HIV negative patients: rifampicin, ethambutol and isoniazid versus rifampicin and ethambutol. Thorax . 2001 Mar. 56(3):167-72. . Griffith DE, Girard WM, Wallace RJ Jr. Clinical features of pulmonary disease caused by rapidly growing mycobacteria

2014 eMedicine.com

247. Mycobacterium Kansasii (Follow-up)

A, Levell N, Munro C. Cutaneous Mycobacterium kansasii infection: case report and review. Clin Infect Dis . 1995 Apr. 20(4):812-7. . Davidson PT. The diagnosis and management of disease caused by M. avium complex, M. kansasii, and other mycobacteria. Clin Chest Med . 1989 Sep. 10(3):431-43. . Fishman JE, Schwartz DS, Sais GJ. Mycobacterium kansasii pulmonary infection in patients with AIDS: spectrum of chest radiographic findings. Radiology . 1997 Jul. 204(1):171-5. . O'Brien RJ. The epidemiology (...) Mycobacterium Kansasii (Follow-up) Mycobacterium Kansasii Treatment & Management: Medical Care, Surgical Care, Consultations Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMjIzMjMwLXRyZWF0bWVudA== processing

2014 eMedicine.com

248. Mycobacterium yongonense in Pulmonary Disease, Italy Full Text available with Trip Pro

Infect Dis 9508155 1080-6040 IM Aged Female Genes, Bacterial Humans Italy Molecular Sequence Data Mycobacterium avium Complex genetics isolation & purification Mycobacterium avium-intracellulare Infection diagnosis Sequence Analysis, DNA Tuberculosis, Pulmonary diagnosis Italy MAC Mycobacterium avium complex Mycobacterium yongonense bacteria cavitary pulmonary disease pulmonary disease respiratory infections tuberculosis and other mycobacteria 2013 11 12 6 0 2013 11 12 6 0 2014 6 10 6 0 ppublish (...) Mycobacterium yongonense in Pulmonary Disease, Italy 24206761 2014 06 09 2018 11 13 1080-6059 19 11 2013 Nov Emerging infectious diseases Emerging Infect. Dis. Mycobacterium yongonense in pulmonary disease, Italy. 1902-4 10.3201/eid1911.130911 Tortoli Enrico E Mariottini Alessandro A Pierotti Piera P Simonetti Tullia M TM Rossolini Gian Maria GM eng GENBANK KF224989 KF224990 KF224991 KF224992 KF224993 KF224994 KF224995 KF224996 KF224997 KF224998 KF224999 Case Reports Letter United States Emerg

2013 Emerging Infectious Diseases

249. Characterization of a Mycobacterium chimaera variant. Full Text available with Trip Pro

within the Mycobacterium avium complex (MAC). However, the cell-wall mycolic acid pattern, analysed by HPLC, and the partial sequences of the hsp65 and rpoB genes were identical to those of M. chimaera. We concluded that the isolates represent a novel variant of M. chimaera. The results of this analysis have led us to question the currently used methods of species definition for members of the genus Mycobacterium, which are based largely on 16S rRNA or rpoB gene sequencing. Definitions based (...) Characterization of a Mycobacterium chimaera variant. In this study, nonchromogenic mycobacteria were isolated from pulmonary samples of three patients in the Netherlands. All isolates had identical, unique 16S rRNA gene and 16S-23S ITS sequences, which were closely related to those of Mycobacterium chimaera and Mycobacterium marseillense. The biochemical features of the isolates differed slightly from those of M. chimaera, suggesting that the isolates may represent a possible separate species

2012 Journal of Medical Microbiology

250. Complete Genome Sequence of Mycobacterium intracellulare Strain ATCC 13950T Full Text available with Trip Pro

Complete Genome Sequence of Mycobacterium intracellulare Strain ATCC 13950T Here we report the first complete genome sequence of Mycobacterium intracellulare ATCC 13950(T), a Mycobacterium avium complex (MAC) strain. This genome sequence will serve as a valuable reference for understanding the epidemiologic, biological, and pathogenic aspects of the disparity between MAC members.

2012 Journal of bacteriology

251. Massive gene acquisitions in Mycobacterium indicus pranii provide a perspective on mycobacterial evolution Full Text available with Trip Pro

significance. Evolutionarily, it is the progenitor of opportunistic pathogens belonging to M. avium complex and is endowed with features that place it between saprophytic and pathogenic species. Herein, we have sequenced the complete MIP genome to understand its unique life style, basis of immunomodulation and habitat diversification in mycobacteria. As a case of massive gene acquisitions, 50.5% of MIP open reading frames (ORFs) are laterally acquired. We show, for the first time for Mycobacterium (...) Massive gene acquisitions in Mycobacterium indicus pranii provide a perspective on mycobacterial evolution Understanding the evolutionary and genomic mechanisms responsible for turning the soil-derived saprophytic mycobacteria into lethal intracellular pathogens is a critical step towards the development of strategies for the control of mycobacterial diseases. In this context, Mycobacterium indicus pranii (MIP) is of specific interest because of its unique immunological and evolutionary

2012 Nucleic acids research

252. Mycobacterium Avium Complex (MAC) Lung Disease in Two Inner City Community Hospitals: Recognition, Prevalence, Co-Infection with Mycobacterium Tuberculosis (MTB) and Pulmonary Function (PF) Improvements After Treatment Full Text available with Trip Pro

Mycobacterium Avium Complex (MAC) Lung Disease in Two Inner City Community Hospitals: Recognition, Prevalence, Co-Infection with Mycobacterium Tuberculosis (MTB) and Pulmonary Function (PF) Improvements After Treatment The purpose of this study was to separate MAC lung disease from colonization and to define indications for treatment.Over 4 years, we evaluated patients who had positive MAC cultures, MAC infection and coinfection with MTB. In the first study, 42 immunocompetent patients

2010 The open respiratory medicine journal

253. Multiplex PCR for detection of clarithromycin resistance and simultaneous species identification of Mycobacterium avium complex. (Abstract)

Multiplex PCR for detection of clarithromycin resistance and simultaneous species identification of Mycobacterium avium complex. Multiplex PCR (mPCR) was established for the simultaneous detection of clarithromycin (CLR) resistance and species identification of Mycobacterium avium complex (MAC). mPCR was tested on 218 MAC clinical isolates. CLR-resistance was detected by mPCR in 31 of 35 isolates identified by a microdilution method. Of the remaining 187 susceptible isolates identified by mPCR (...) , 183 isolates had MIC < or = 8 microg/ml (susceptible), 3 with MIC of 16 (intermediate resistant) and 1 with MIC of > or = 32 microg/ml (resistant). Comparing with the PCR-restriction enzyme analysis, mPCR concordantly identified 185 isolates either as being M. avium or M. intracellulare, whereas one isolate was misidentified and 32 isolates could not be identified. Comparing with reference methods, the mPCR showed the sensitivity, specificity, positive predictive and negative predictive value

2010 Southeast Asian Journal of Tropical Medicine and Public Health

254. Hospital Water Filters as a Source of Mycobacterium avium Complex. Full Text available with Trip Pro

Hospital Water Filters as a Source of Mycobacterium avium Complex. Bronchoscopes and the filters used for washing them were found to yield high numbers of Mycobacterium avium isolates sharing the same repetitive sequence-based PCR (rep-PCR) fingerprint pattern as M. avium isolates recovered from patient samples collected by bronchoscopy. Water and biofilm samples collected from the bronchoscopy preparation laboratory yielded M. avium, Mycobacterium intracellulare, Mycobacterium malmoense (...) and Mycobacterium gordonae. Several M. avium and M. intracellulare isolates from water samples in the bronchoscopy laboratory had rep-PCR patterns matching those of patient bronchoscopy isolates. Five of the 22 (23 %) M. avium patient bronchoscopy isolates and 42 of the 56 (75 %) M. intracellulare patient bronchoscopy isolates could have been due to contamination from the water supply.

2010 Journal of Medical Microbiology

255. PCR amplification and high resolution melt curve analysis as a rapid diagnostic method to genotype members of the Mycobacterium avium-intracellulare complex. Full Text available with Trip Pro

PCR amplification and high resolution melt curve analysis as a rapid diagnostic method to genotype members of the Mycobacterium avium-intracellulare complex. Some of the members of the Mycobacterium avium–intracellulare (MAI) complex are recognized as human pathogens in both immunocompromised and immunocompetent patients. The current molecular methods that are available for genotyping the MAI complex members can be both expensive and technically demanding. In this report, we describe (...) for the first time the application of a real-time PCR and high-resolution melt approach to differentiate between the complex members by targeting a member of the Pro- Pro-Glu gene family, MACPPE24. To this end, reference strains of the M. avium subspecies and Mycobacterium intracellulare were used to optimize the technique. Then, this real-time PCR–high-resolution melt approach was used to distinguish ten M. avium ssp. hominissuis field isolates from the M. intracellulare reference strain.

2010 Clinical Microbiology and Infection

256. Lady Windermere Syndrome After Cardiac Surgery Procedure: A Case of Mycobacterium avium Complex Pneumonia. (Abstract)

Lady Windermere Syndrome After Cardiac Surgery Procedure: A Case of Mycobacterium avium Complex Pneumonia. We present a patient with Lady Windermere syndrome after coronary bypass operation. To avoid the sternal pain that occurred after every cough episode, this patient used to receive large doses of antitussive drugs. In a poorly drained lung, this usage leads to the development of regions of colonization with Mycobacterium avium complex. It is concerning that the lack of diagnosis for 18

2010 Annals of Thoracic Surgery

257. Clinical usefulness of combination chemotherapy for pulmonary Mycobacterium avium complex disease. (Abstract)

Clinical usefulness of combination chemotherapy for pulmonary Mycobacterium avium complex disease. BACKGROUND: This study compared the clinical usefulness of combination chemotherapy including various doses of clarithromycin (CAM) for pulmonary Mycobacterium avium complex (MAC) disease. METHODS: The subjects were divided into three groups receiving combination chemotherapy at various dose levels of CAM. The analysis of microbiological effects was based on the sputum conversion rate and sputum

2010 Journal of Infection

258. Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis. Full Text available with Trip Pro

ascites were identified and compared according to causative pathogens (Mycobacterium tuberculosis or NTM). Those with NTM peritonitis were further classified into the 'probable' and 'possible' groups based on diagnostic evidence. Twenty-five patients with NTM peritonitis and 65 with tuberculous peritonitis were reviewed. Mycobacterium avium complex was the most common NTM pathogen (52%). There was no obvious difference between the 'probable' and 'possible' NTM peritonitis groups regarding age (...) Mycobacterial peritonitis: difference between non-tuberculous mycobacteria and Mycobacterium tuberculosis. Unlike tuberculous peritonitis, peritonitis due to non-tuberculous mycobacteria (NTM) has unclear clinical manifestations. This study aimed to clarify the clinical manifestations and laboratory results of NTM peritonitis and compare it to tuberculous peritonitis. This retrospective study was conducted from 2000 to 2008 in a medical centre in Taiwan. Patients with mycobacteria isolated from

2011 Clinical Microbiology and Infection

259. Mimicry of the Pathogenic Mycobacterium Vacuole In Vitro Elicits the Bacterial Intracellular Phenotype, Including Early-Onset Macrophage Death Full Text available with Trip Pro

Mimicry of the Pathogenic Mycobacterium Vacuole In Vitro Elicits the Bacterial Intracellular Phenotype, Including Early-Onset Macrophage Death Mycobacterium avium complex (MAC) within macrophages undergoes a phenotype change that allows for more efficient entry into surrounding host cells. We hypothesized that, by developing an in vitro system resembling the intravacuolar environment, one could generate insights into the mycobacterial intracellular phenotype. MAC was incubated in "elemental (...) of the intracellular phenotype. It was demonstrated that bacteria harboring the intracellular phenotype induced early-onset macrophage death more efficiently than bacteria grown in broth. This new trace elemental mixture mimicking the condition of the vacuole at different time points has the potential to become an effective laboratory tool for the study of the MAC and Mycobacterium tuberculosis disease process, increasing the understanding of the interaction with macrophages.

2011 Infection and immunity

260. Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. (Abstract)

Antibiotic treatment for nontuberculous mycobacteria lung infection in people with cystic fibrosis. Nontuberculous mycobacteria are mycobacteria, other than those in the Mycobacterium tuberculosis complex, and are commonly found in the environment. Nontuberculous mycobacteria species (most commonly Mycobacterium avium complex and Mycobacterium abscessus) are isolated from the respiratory tract of approximately 5% to 40% of individuals with cystic fibrosis; they can cause lung disease in people (...) for the effectiveness of different antimicrobial treatment for nontuberculous mycobacteria lung disease in people with cystic fibrosis. Until such evidence becomes available, it is reasonable for clinicians to follow published clinical practice guidelines for the diagnosis and treatment of nodular or bronchiectatic pulmonary disease due to Mycobacterium avium complex or Mycobacterium abscessus in patients with cystic fibrosis.Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

2020 Cochrane

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>